Compare Sinarmas Multiartha Tbk. (SMMA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinarmas Multiartha Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Sinarmas Multiartha Tbk. trades at Rp20,600 (market cap 131.17T), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Sinarmas Multiartha Tbk. is far larger — about 11.2× Tempo Scan Pacific Tbk.'s market cap. Which is the better fit depends on your goals.
| SMMA | TSPC | |
|---|---|---|
Market Cap | 131.17T | 11.68T |
Volume | — | 429.7K |
Lot | — | 4.3K |
Turnover | — | 1.11B |
Average Price | — | 2,591.65 |
Value | — | 1.11B |
Indicative Equilibrium Price | — | 2,580 |
Indicative Equilibrium Volume | — | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinarmas Multiartha Tbk.
PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Read more on SMMA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
